昆山龙灯瑞迪制药有限公司-关于我们

Company Profile

Kunshan Rotam Reddy Pharmaceutical Co., Ltd. (KRRP) was jointly invested and established by Rotam Group of Canada and Dr. Reddys Laboratories Ltd. of India in 2000. Located in Kunshan Economic and Technological Development Zone, Jiangsu Province, the company has good infrastructure and sufficient technical talents, and unique regional advantages to attract investment. At the same time, it also has established branches and offices in Shanghai, Beijing, Guangzhou, Tianjin, Nanjing, Hangzhou, Fuzhou, Wuhan and other cities.

About KRRP

Over more than 20 years since its establishment, KRRP has adhered to the concept that "Patients Come First and Good Health Can't Wait". It specializes in the core therapeutic areas with strategic significance, keeps exploring the upgrade of therapeutic method and the introduction of innovative drugs, truly promotes the emergence of high-quality products with cutting-edge technology, cuts down the medical costs of patients, heightens the quality of life of patients, and makes remitting efforts to promote the development of the disease field.

Ever since its establishment in 2000, KRRP has mainly delivered global innovative drugs to patients in major disease fields like：

Group Information

Canada Rotam Group

With over 40 branches worldwide

Head quartered in Vancouver, Canada Rotam Group has more than 3,000 employees and more than 40 branches worldwide, including 11 offices in Europe and Asia and a production base for life science products in Asia. The company's business is centered on life science and involves multiple fields, including pesticides, pharmaceuticals, veterinary medicines and packaging materials.

The goal of the company is to use advanced science and technology in the field of life science, so as to provide high-quality products and humanized services, and meet the needs of consumers for life science products.
India Dr. Reddy's

With business covering more than 74 countries and territories around the world

As a global pharmaceutical producer, Dr. Reddy's Laboratories's products and medical services cover a wide range of therapeutic fields. Its business scope includes pharmaceutical services, active pharmaceutical ingredients (APIs), global generic drugs, patent drugs and biological generic drugs, covering 74 countries worldwide.

It has been more than two decades since Dr. Reddy's Laboratories started its business in China, and now, Dr. Reddy's Laboratories has become the biggest multinational producer of imported generic drugs in China. In 2000, Dr. Reddy's Laboratories and Rotam Group jointly established Kunshan Rotam Reddy Pharmaceutical Co., Ltd. in China, a joint venture engaged in production, sales and marketing. In 2010, the Reddy (Beijing) representative office was established to manage regulatory affairs and registration of import drugs. In 2020, as part of the expansion plan, Dr. Reddy′s (Beijing) Pharmaceutical Co., Ltd. was established to carry out relevant commercial activities in China.

Dr. Reddy's business in China focuses on a variety of therapeutic fields, including oncology, diabetes and central nervous system and cardiovascular diseases. Centering on the core concept of "Good Health Can’t Wait", Reddy is accelerating its commitment to producing affordable innovative medicines, constantly seeking to tap into new therapeutic fields, and introducing proprietary products to address the unmet health needs of Chinese patients.

1994
1999
2000
2003
2004
2006
2009
2012
2014
2017
2020
2022
2023

0 1 2 3 4 5 6 7 8 9

0 1 2 3 4 5 6 7 8 9
0 1 2 3 4 5 6 7 8 9

0 1 2 3 4 5 6 7 8 9

Development Story

January

Establishment of Kunshan Rotam Pharmaceutical Co, Ltd.
April

The first imported sub-packaged to bnicate and naphthylacetic acil product as approved

October

The first new drug "Benzbromarone Tablet" was approved
June

Establishment of the joint venture company: Kunshan Rotam Reddy Pharmaceutical Co., Ltd.

August

Obtaining the first GMP certificate
August

Four new drugs "ramipril" were approved
March

The API workshop has been officially completed
February

Establishment of a new business model for pharmaceutical products
January

Sales exceeding 100 million yuan

May

Establishing Rotem Reddy Shanghai Office
September

The new administrative building of the headquarters was officially put into use
March

Successfully passed the new GMP certification
January

The new factory workshop one, workshop two, and warehouse projects have been approved for project approval
March

Formal establishment of Kunshan Rotam Reddy Pharmaceutical Co., Ltd

The new factory workshop one, workshop two, and warehouse project have officially started construction

September

Obtaining GSP License Certificate

October

Selected as the 12th batch of headquarters enterprises by the Kunshan Municipal Government
November

Selected in the list of specialized, delicate, special and innovate SMEs in Jiangsu Province in 2022 (the 2nd batch)
August

Planned acceptance permit was attained for the new factory project

Corporate Honors

Honored as one of the Certified Science and Technology Research Centers in Kunshan City .
Includedin the list of Certified Hightech Enteprises in Kunshan City
Honoredas one of the FreifnFunded R&D Institutions in Jjiangsu Province
Honored as one of the First Batch of Enterprises with Harmonious Labor Relationsin Kunshan City
Honored as a Medicine Donation Unit Recognized by the Red Cross Society of Jiangsu Province .
Selected as one of the First Batch of Enterprises with Harmonious Labor Relations in Kunshan City
Selected as one of the A-level Labor Security Reputation Units of Kunshan City
Recognized as one of the 12th Batch of Headquarters Enterprises by the Kunshan Municipal Government
Included in the list of Class A Enterprises of Intensive Resource Utilization in Suzhou City in 2020
Three products were included in the 2022 “Famous Product Catalog of Suzhou' s Biomedical and Health Industry Innovation
Included in the list of specialized, special and new SMEs in Jiangsu Province in 2022 (the 2nd batch)

Product development

The products developed by our company mainly focus on cardiovascular and cerebrovascular diseases, endocrine diseases, central nervous system diseases, skin diseases, digestive system diseases, rheumatoid diseases, AIDS, anti-tumor and other areas. So far, our company has obtained 27 marketing licenses for drugs. Relying on the strong R&D capability of the parent company, Dr. Reddy’s Laboratories Ltd. of India, our company is now developing more than 40 products, and has submitted.

While doing well in the existing products, we also continue to cooperate with medical experts in depth to explore new treatment directions for diseases, so that patients can have more and better treatment options and obtain more scientific treatment plans.

Laboratory Facilities

The R&D center has functional units that meet different R&D needs, mainly including formulation R&D laboratories, analysis laboratories, pilot workshops, and commercial scale process validation workshops. The analytical laboratory has many analytical instruments, such as advanced high performance liquid chromatograph, gas chromatograph, diode display detector, automatic potentiometric titration, Malvern laser particle size analyzer, automatic dissolution tester, ultraviolet spectrophotometer, infrared spectrophotometer, near-infrared spectrophotometer, proton absorption spectrophotometer, electronic Analytical balance, ultraviolet analyzer, etc. The equipment used in the research and development of formulations mainly includes multifunctional fluidized beds, rapid stirring granulators, wet and dry granulators, crushing granulators, multi-directional motion mixers, fully automatic capsule filling machines, oscillating screening machines, high-efficiency coating machines, centrifugal screening machines, powder testers, high-speed packaging machines, high-speed tablet presses, high-speed screening machines, vacuum feeding machines, boiling dryers, three-dimensional transparent film packaging machines, and stability test boxes.
LEARN MORE
R&D Center

The company's R&D center was officially established in 2000 and was certified by a foreign-funded R&D institution in Jiangsu Province in 2008. We are closely cooperating with the global R&D center of our parent company,Dr. Reddy’s Laboratories Ltd. of India, and are committed to providing high-quality and affordable chemical drugs to Chinese patients. The company has a highly specialized research and development technical team, which is well versed in the policies, regulations, technical requirements, and registration requirements in the field of chemical drug research and development. It is fully responsible for the entire process and management of preclinical research, clinical research, pharmaceutical research, drug registration, and obtaining marketing license qualifications. At the same time, the scientific and rigorous management system of the R&D center with clear division of labor ensures the progress, quality, and registration success rate of R&D projects.
LEARN MORE